Related Experiment Video

Updated: Apr 30, 2026

Bacterial Delivery of RNAi Effectors: Transkingdom RNAi
07:56

Bacterial Delivery of RNAi Effectors: Transkingdom RNAi

Published on: August 18, 2010

13.2K

Targeting ribonucleotide reductase M2 subunit by small interfering RNA exerts anti-oncogenic effects in gastric

Wei Kang1, Joanna H M Tong1, Anthony W H Chan1

  • 1Department of Anatomical and Cellular Pathology, State Key Laboratory in Oncology in South China, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, P.R. China.

Oncology Reports
|April 24, 2014
PubMed

Insights

Ribonucleotide reductase M2 subunit (RRM2) is upregulated in gastric cancer, correlating with poor prognosis. Inhibiting RRM2 suppressed tumor growth, invasion, and promoted apoptosis, indicating its potential as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Ribonucleotide reductase M2 subunit (RRM2) is essential for DNA synthesis and is implicated in tumor progression.
  • Its role in gastric adenocarcinoma requires further investigation for potential therapeutic applications.

Purpose of the Study:

  • To investigate the expression, clinical significance, and biological functions of RRM2 in gastric adenocarcinoma.
  • To evaluate RRM2 as a prognostic marker and therapeutic target in gastric cancer.

Main Methods:

  • Analysis of RRM2 mRNA and protein expression in gastric cancer cell lines and paired tumor/non-tumor tissues.
  • Correlation analysis of RRM2 expression with clinical parameters (tumor grade, T stage, survival).
  • In vitro (cell lines) and in vivo (xenograft) studies to assess the functional impact of RRM2 knockdown.

Main Results:

  • RRM2 was significantly upregulated in gastric cancer cell lines and primary tumors compared to non-tumorous tissues.
  • RRM2 expression correlated with higher tumor grade, advanced T stage, and poorer disease-specific survival.
  • RRM2 knockdown suppressed gastric cancer cell proliferation, colony formation, invasion, induced apoptosis, and inhibited xenograft tumor growth.

Conclusions:

  • RRM2 plays a critical role in gastric tumorigenesis.
  • RRM2 serves as a potential prognostic biomarker for gastric cancer.
  • RRM2 represents a promising therapeutic target for gastric cancer treatment.

More Related Videos

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

1.3K
Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

18.5K

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
24.3K
RNA Interference01:23

RNA Interference

6.4K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
13.4K